Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Retinal disorders
- Focus Therapeutic Use
- 18 Feb 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Dec 2014 to 1 Dec 2015.
- 18 Feb 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 03 Dec 2013 New trial record